Drug Profile
HW 1101
Alternative Names: HW-1101Latest Information Update: 28 Aug 2020
Price :
$50
*
At a glance
- Originator Nanjing Huawe Medicine Technology Development
- Class Anti-infectives
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Bacterial infections; Viral infections
Most Recent Events
- 28 Aug 2020 No recent reports of development identified for preclinical development in Bacterial-infections in China
- 28 Aug 2020 No recent reports of development identified for preclinical development in Viral-infections in China
- 29 Jul 2016 Preclinical trials in Bacterial infections in China (unspecified route)